BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25816819)

  • 1. Invited commentary: Estimating population impact in the presence of competing events.
    Naimi AI; Tchetgen Tchetgen EJ
    Am J Epidemiol; 2015 Apr; 181(8):571-4. PubMed ID: 25816819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invited commentary: G-computation--lost in translation?
    Vansteelandt S; Keiding N
    Am J Epidemiol; 2011 Apr; 173(7):739-42. PubMed ID: 21415028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothetical exposure limits for oil-based metalworking fluids and cardiovascular mortality in a cohort of autoworkers: structural accelerated failure time models in a public health framework.
    Picciotto S; Peters A; Eisen EA
    Am J Epidemiol; 2015 Apr; 181(8):563-70. PubMed ID: 25816818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A causal framework for classical statistical estimands in failure-time settings with competing events.
    Young JG; Stensrud MJ; Tchetgen Tchetgen EJ; Hernán MA
    Stat Med; 2020 Apr; 39(8):1199-1236. PubMed ID: 31985089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invited Commentary: Causal Inference Across Space and Time-Quixotic Quest, Worthy Goal, or Both?
    Edwards JK; Lesko CR; Keil AP
    Am J Epidemiol; 2017 Jul; 186(2):143-145. PubMed ID: 28679174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The implementation of medical monitoring programs following potentially hazardous exposures: a medico-legal perspective.
    Vearrier D; Greenberg MI
    Clin Toxicol (Phila); 2017 Nov; 55(9):956-969. PubMed ID: 28644057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invited Commentary: Agent-Based Models-Bias in the Face of Discovery.
    Keyes KM; Tracy M; Mooney SJ; Shev A; Cerdá M
    Am J Epidemiol; 2017 Jul; 186(2):146-148. PubMed ID: 28673036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inverse Probability Weighting to Estimate Exposure Effects on the Burden of Recurrent Outcomes in the Presence of Competing Events.
    Gaber CE; Edwards JK; Lund JL; Peery AF; Richardson DB; Kinlaw AC
    Am J Epidemiol; 2023 May; 192(5):830-839. PubMed ID: 36790815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to letter to the editor from Dr Rahman Shiri: The challenging topic of suicide across occupational groups.
    Niedhammer I; Milner A; Witt K; Klingelschmidt J; Khireddine-Medouni I; Alexopoulos EC; Toivanen S; Chastang JF; LaMontagne AD
    Scand J Work Environ Health; 2018 Jan; 44(1):108-110. PubMed ID: 29218357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Causal inference in the face of competing events.
    Rudolph JE; Lesko CR; Naimi AI
    Curr Epidemiol Rep; 2020 Sep; 7(3):125-131. PubMed ID: 33747714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating causal effects in the presence of competing events using regression standardisation with the Stata command standsurv.
    Syriopoulou E; Mozumder SI; Rutherford MJ; Lambert PC
    BMC Med Res Methodol; 2022 Aug; 22(1):226. PubMed ID: 35963987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Instrumental variables and inverse probability weighting for causal inference from longitudinal observational studies.
    Hogan JW; Lancaster T
    Stat Methods Med Res; 2004 Feb; 13(1):17-48. PubMed ID: 14746439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invited commentary: Agent-based models for causal inference—reweighting data and theory in epidemiology.
    Hernán MA
    Am J Epidemiol; 2015 Jan; 181(2):103-5. PubMed ID: 25480820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating health outcomes in the presence of competing risks: a review of statistical methods and clinical applications.
    Varadhan R; Weiss CO; Segal JB; Wu AW; Scharfstein D; Boyd C
    Med Care; 2010 Jun; 48(6 Suppl):S96-105. PubMed ID: 20473207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Covariate adjustment of cumulative incidence functions for competing risks data using inverse probability of treatment weighting.
    Neumann A; Billionnet C
    Comput Methods Programs Biomed; 2016 Jun; 129():63-70. PubMed ID: 27084321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating the potential impacts of intervention from observational data: methods for estimating causal attributable risk in a cross-sectional analysis of depressive symptoms in Latin America.
    Fleischer NL; Fernald LC; Hubbard AE
    J Epidemiol Community Health; 2010 Jan; 64(1):16-21. PubMed ID: 19643766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performing Survival Analyses in the Presence of Competing Risks: A Clinical Example in Older Breast Cancer Patients.
    de Glas NA; Kiderlen M; Vandenbroucke JP; de Craen AJ; Portielje JE; van de Velde CJ; Liefers GJ; Bastiaannet E; Le Cessie S
    J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26614095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolving methods for inference in the presence of healthy worker survivor bias.
    Buckley JP; Keil AP; McGrath LJ; Edwards JK
    Epidemiology; 2015 Mar; 26(2):204-12. PubMed ID: 25536456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safe handling of hazardous drugs: are you protected?
    Nixon S; Schulmeister L
    Clin J Oncol Nurs; 2009 Aug; 13(4):433-9. PubMed ID: 19648100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Straight Metalworking Fluids and All-Cause and Cardiovascular Mortality Analyzed by Using G-Estimation of an Accelerated Failure Time Model With Quantitative Exposure: Methods and Interpretations.
    Picciotto S; Ljungman PL; Eisen EA
    Am J Epidemiol; 2016 Apr; 183(7):680-8. PubMed ID: 26968943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.